Navigation Links
Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies
Date:3/20/2012

IRVING, Texas, March 20, 2012 /PRNewswire/ -- Novation, the leading health care supply contracting company, announces the release of its most recent Transcatheter Cardiovascular Therapeutics Report.  This report is produced by Novation's cardiology staff and is intended to help VHA, UHC and Provista members understand and prepare for new cardiology technologies.

The Novation cardiology team compiled this report following their attendance late last year at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting.  The TCT is the world's largest educational meeting specializing in interventional cardiovascular medicine and the latest advances in current therapies and clinical research.  The conference also showcases technologies and devices not yet available in the United States.

By attending the TCT meeting and learning about new trends and devices, the Novation cardiovascular team can advise members about the impact of upcoming technologies before they are approved by the U.S. Food and Drug Administration. 

Novation's report focuses on several emerging technologies and trends. Areas of focus in this report include transcatheter aortic valve replacement, high blood pressure therapy, drug-eluting balloons, and bioabsorbable coronary stents, as well as coronary, peripheral vascular, structural heart, and heart rhythm products and technology trends.

Some of the devices, such as the percutaneous heart valves, have recently been approved. Other products, such as the drug-eluting balloon, bioabsorbable coronary stent and renal denervation, are in clinical trials and device development, but demonstrate promising early results. This report highlights these and other new cardiovascular devices in a condensed format.

"The intent of our report is to provide clinical and economic highlights of these new technologies that have a high probability of impacting the member hospitals we serve," said Michael Vintges, vice president, physician preference, contract and program services, Novation.  "Novation is committed to helping the hospitals we serve continue to provide the highest quality care, while simultaneously driving supply costs down."

To view the entire report, please visit https://www.novationco.com/pressroom/industry_info.

About Novation, Winner of the Ethics Inside® Certification

Founded in 1998, Novation is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Tex, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, and Provista members used Novation contracts to purchase more than $40 billion in products and services in 2011. Novation recently earned the coveted Ethics Inside® Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance, and is the only health care group purchasing organization to earn this distinction.


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
2. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
3. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
4. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
5. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
6. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
7. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
8. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
9. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
10. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
11. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... Iowa , June 6, 2017  Diplomat Specialty Infusion Group, ... sterile compounding environment to its Iowa location. ... Urbandale now features an ISO 7 cleanroom—the standard ... controlled environment with a low level of pollutants. ... more IV nutrition consumers and better serve our Iowa ...
(Date:6/1/2017)... 1, 2017 Nutriceutical Holdings (NH), parent company ... (VRS), and KD Pharma Group have decided to join ... KD Pharma Group. KD Pharma Group will become the ... acquire the entire company. "We believe we ... committed to growing the NH companies by providing us ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... ... All-Star Insurance, a family managed agency that offers insurance management assistance and personal ... of a new charity drive to benefit women in the area diagnosed with breast ... estimated 252, 710 new cases of invasive or high risk breast cancer will be ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... 2017 , ... Despite its pervasiveness, many physicians are unfamiliar with how best ... with clinical practice. Now, however, a timely review has been published in the ... etiology of NeuP and educating preclinical scientists on its diagnosis and choice of treatment. ...
(Date:6/22/2017)... ... June 23, 2017 , ... Rise Against Hunger ... June 21, 2017, at the Emeryville Center of Community Life. More than 374 ... world. , Rise Against Hunger (formerly Stop Hunger Now) meal packaging events are ...
(Date:6/20/2017)... , ... June 20, 2017 , ... After months of negotiations, FaceCradle USA is proud ... on Wednesday, June 21. , “Introducing our product on QVC is something we all ... promote our travel pillow to more than 90 million homes in the United States,” said ...
Breaking Medicine News(10 mins):